Literature DB >> 21377551

Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes?

J Enrique Domínguez-Muñoz1.   

Abstract

Exocrine pancreatic insufficiency with steatorrhea is a major consequence of chronic pancreatitis. Recognition of this entity is highly relevant to avoid malnutrition-related morbidity and mortality. Nutritional counseling and oral pancreatic enzyme replacement are the basis for the therapy for exocrine pancreatic insufficiency. Aim of enzyme therapy is not only to avoid symptoms but also to normalize digestion. With this aim, oral administration of pancreatic enzymes in the form of enteric-coated minimicrospheres is the therapy of choice. This enzyme preparation avoids acid-mediated lipase inactivation and ensures gastric emptying of enzymes in parallel with nutrients. Despite that, factors like an acidic intestinal pH and bacterial overgrowth may prevent normalization of fat digestion even in compliant patients. The present article reviews the current evidence on therapy of exocrine pancreatic insufficiency in chronic pancreatitis patients, with special attention to different potential endpoints to select the optimal enzyme dose for individual patients.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377551     DOI: 10.1016/j.cgh.2011.02.027

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  14 in total

1.  Sustained gastrointestinal activity of dendronized polymer-enzyme conjugates.

Authors:  Gregor Fuhrmann; Andrea Grotzky; Ružica Lukić; Simon Matoori; Paola Luciani; Hao Yu; Baozhong Zhang; Peter Walde; A Dieter Schlüter; Marc A Gauthier; Jean-Christophe Leroux
Journal:  Nat Chem       Date:  2013-06-09       Impact factor: 24.427

Review 2.  Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives.

Authors:  Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2013-11-02       Impact factor: 4.200

Review 3.  [Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Sandra Zlamal-Fortunat; Heinz F Hammer
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

4.  Pancreatic enzyme therapy for pancreatic exocrine insufficiency.

Authors:  J Enrique Domínguez-Muñoz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-06

5.  Systematic review and meta-analysis: Small intestinal bacterial overgrowth in chronic pancreatitis.

Authors:  Gabriele Capurso; Marianna Signoretti; Livia Archibugi; Serena Stigliano; Gianfranco Delle Fave
Journal:  United European Gastroenterol J       Date:  2016-02-03       Impact factor: 4.623

Review 6.  Nutrition in chronic pancreatitis.

Authors:  Henrik Højgaard Rasmussen; Oivind Irtun; Søren Schou Olesen; Asbjørn Mohr Drewes; Mette Holst
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 7.  Diagnosis and treatment of pancreatic exocrine insufficiency.

Authors:  Björn Lindkvist
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

8.  Right atrium floating thrombus and bilateral pulmonary embolism in a patient with pancreatic pseudocyst.

Authors:  Diana Alexandra Cherata; Ionut Donoiu; Oana Mirea; Rodica Diaconu; Octavian Istratoaie
Journal:  J Cardiol Cases       Date:  2018-05-26

9.  [Position paper: Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Werner Fortunat; Heinz Hammer
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

Review 10.  Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.

Authors:  Tony Trang; Johanna Chan; David Y Graham
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.